Should studies of maintenance therapy be maintained in women with ovarian cancer?

por Bookman, Michael A.
Publicado 2013

A phase I study of paclitaxel, topotecan, cisplatin and Filgrastim in patients with newly diagnosed advanced ovarian epithelial malignancies: A Gynecologic Oncology group study

por Armstrong, Deborah K., Bookman, Michael A., McGuire, William, Bristow, Robert E., Schilder, Jeanne M.
Publicado 2007

Advanced Stage Mucinous Adenocarcinoma of the Ovary is both Rare and Highly Lethal: A Gynecologic Oncology Group Study

por Zaino, Richard J., Brady, Mark F., Lele, Subodh M., Michael, Helen, Greer, Benjamin, Bookman, Michael A.
Publicado 2010

Independent radiologic review of the Gynecologic Oncology Group Study 0218, a phase III trial of bevacizumab in the primary treatment of advanced epithelial ovarian, primary perito...

por Burger, Robert. A., Brady, Mark F., Rhee, Joon, Sovak, Mika A., Kong, George, Nguyen, Hoa P., Bookman, Michael A.
Publicado 2013

Survival in Women With Grade 1 Serous Ovarian Carcinoma

por Fader, Amanda Nickles, Java, James, Ueda, Stefanie, Bristow, Robert E., Armstrong, Deborah K., Bookman, Michael A., Gershenson, David M.
Publicado en Obstet Gynecol (2013)

Does Aggressive Surgery Improve Outcomes? Interaction Between Preoperative Disease Burden and Complex Surgery in Patients With Advanced-Stage Ovarian Cancer: An Analysis of GOG 182

por Horowitz, Neil S., Miller, Austin, Rungruang, Bunja, Richard, Scott D., Rodriguez, Noah, Bookman, Michael A., Hamilton, Chad A., Krivak, Thomas C., Maxwell, G. Larry
Publicado en J Clin Oncol (2015)

Factors associated with guideline-concordant use of radiation therapy after mastectomy in the National Comprehensive Cancer Network

por Punglia, Rinaa S., Hughes, Melissa E., Edge, Stephen B., Theriault, Richard L., Bookman, Michael A., Wilson, John L., Ottesen, Rebecca A., Niland, Joyce C., Weeks, Jane C.
Publicado 2008

Selecting High Priority Quality Measures for Breast Cancer Quality Improvement

por Hassett, Michael J., Hughes, Melissa E., Niland, Joyce C., Ottesen, Rebecca, Edge, Stephen B., Bookman, Michael A., Carlson, Robert W., Theriault, Richard L., Weeks, Jane C.
Publicado 2008

The prognostic significance of pre- and post-treatment CA-125 in grade 1 serous ovarian carcinoma: A Gynecologic Oncology Group study(, )

por Fader, Amanda Nickles, Java, James, Krivak, Thomas C., Bristow, Robert E., Tergas, Ana I., Bookman, Michael A., Armstrong, Deborah K., Tanner, Edward J., Gershenson, David M.
Publicado en Gynecol Oncol (2013)

PACLITAXEL POLIGLUMEX AND CARBOPLATIN AS FIRST-LINE THERAPY IN OVARIAN, PERITONEAL OR FALLOPIAN TUBE CANCER: A PHASE I AND FEASIBILITY TRIAL OF THE GYNECOLOGIC ONCOLOGY GROUP

por Morgan, Mark A., Darcy, Kathleen M., Rose, Peter G., DeGeest, Koen, Bookman, Michael A., Aikins, James K., Sill, Michael W., Mannel, Robert S., Allievi, Cecilia, Egorin, Merrill J.
Publicado 2008

Pre-Treatment Tumor Expression of ERCC1 in Women with Advanced Stage Epithelial Ovarian Cancer is Not Predictive of Clinical Outcomes: A Gynecologic Oncology Group Study

por Rubatt, Jennifer M., Darcy, Kathleen M., Tian, Chunqiao, Muggia, Franco, Dhir, Rajiv, Armstrong, Deborah K., Bookman, Michael A., Niedernhofer, Laura J., Deloia, Julie, Birrer, Michael, Krivak, Thomas Carl
Publicado 2012

Better Therapeutic Trials in Ovarian Cancer

por Bookman, Michael A., Gilks, C. Blake, Kohn, Elise C., Kaplan, Karen O., Huntsman, David, Aghajanian, Carol, Birrer, Michael J., Ledermann, Jonathan A., Oza, Amit M., Swenerton, Kenneth D.
Publicado 2014

Speeding up the Evaluation of New Agents in Cancer

por Parmar, Mahesh K. B., Barthel, Friederike. M.-S., Sydes, Matthew, Langley, Ruth, Kaplan, Rick, Eisenhauer, Elizabeth, Brady, Mark, James, Nicholas, Bookman, Michael A., Swart, Ann-Marie, Qian, Wendi, Royston, Patrick
Publicado 2008

Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecolo...

por Tian, Chunqiao, Ambrosone, Christine B, Darcy, Kathleen M, Krivak, Thomas C, Armstrong, Deborah K., Bookman, Michael A, Davis, Warren, Zhao, Hua, Moysich, Kirsten, Gallion, Holly, DeLoia, Julie A
Publicado 2011

Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: An NRG Oncology/GOG study

por Ferriss, James S, Java, James J, Bookman, Michael A, Fleming, Gini F, Monk, Bradley J, Walker, Joan L, Homesley, Howard D, Fowler, Jeffrey, Greer, Benjamin E, Boente, Matthew P, Burger, Robert A
Publicado en Gynecol Oncol (2015)

Does Adjuvant Chemotherapy Dose Modification Have an Impact On the Outcome of Patients diagnosed with Advanced Stage Ovarian Cancer? An NRG Oncology/Gynecologic Oncology Group Stud...

por Olawaiye, Alexander B., Java, James J., Krivak, Thomas C., Friedlander, Michael, Mutch, David G., Glaser, Gretchen, Geller, Melissa, O’Malley, David M., Wenham, Robert M., Lee, Roger B., Bodurka, Diane C., Herzog, Thomas J., Bookman, Michael A.
Publicado en Gynecol Oncol (2018)

Corrigendum to “Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Onc...

por Olawaiye, Alexander B., Java, James J., Krivak, Thomas C., Friedlander, Michael, Mutch, David G., Glaser, Gretchen, Geller, Melissa, O'Malley, David M., Wenham, Robert M., Lee, Roger B., Bodurka, Diane C., Herzog, Thomas J., Bookman, Michael A.
Publicado en Gynecol Oncol (2018)

Risk Factors for GI Adverse Events in a Phase III Randomized Trial of Bevacizumab in First-Line Therapy of Advanced Ovarian Cancer: A Gynecologic Oncology Group Study

por Burger, Robert A., Brady, Mark F., Bookman, Michael A., Monk, Bradley J., Walker, Joan L., Homesley, Howard D., Fowler, Jeffrey, Greer, Benjamin E., Boente, Matthew, Fleming, Gini F., Lim, Peter C., Rubin, Stephen C., Katsumata, Noriyuki, Liang, Sharon X.
Publicado 2014

What is the Role of Retroperitoneal Exploration in Optimally Debulked Stage IIIC Epithelial Ovarian Cancer?: An NRG Oncology/Gynecologic Oncology Group Ancillary Data Study

por Rungruang, Bunja, Miller, Austin, Krivak, Thomas C., Horowitz, Neil, Rodriguez, Noah, Hamilton, Chad A., Backes, Floor J., Carson, Linda, Friedlander, Michael, Mutch, David G., Goodheart, Michael J., Tewari, Krishnansu S., Wenham, Robert M., Bookman, Michael A., Maxwell, G. Larry, Richard, Scott D.
Publicado en Cancer (2016)

Use and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian Cancer

por Meyer, Larissa A., Cronin, Angel M., Sun, Charlotte C., Bixel, Kristin, Bookman, Michael A., Cristea, Mihaela C., Griggs, Jennifer J., Levenback, Charles F., Burger, Robert A., Mantia-Smaldone, Gina, Matulonis, Ursula A., Niland, Joyce C., O’Malley, David M., Wright, Alexi A.
Publicado en J Clin Oncol (2016)